Clinical Trial Update: A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating nerandomilast for systemic sclerosis, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Nerandomilast

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Systemic Sclerosis | Phase 3 | Status: NOT_YET_RECRUITING